Tronox Reports Fourth Quarter 2015 Financial Results
Feb 23, 2016 - Press Releases
net loss of
“This performance is particularly noteworthy, in our view, because it was accomplished despite the headwind of continued selling price declines in pigment products. TiO2 market conditions remained challenging in the fourth quarter. Compared to the year-ago quarter, pigment sales volumes were up 7 percent but average selling prices were 22 percent lower (and 5 percent lower than the third quarter). Feedstock volumes were mixed and selling prices declined. We continue to believe pigment selling prices are at unsustainably low levels. In December, we announced a price increase that we continue to push in all markets and regions.”
Casey continued: “Our Alkali business is a strong complement to our TiO2 business. In the fourth quarter, Alkali generated
Casey concluded: “Our cash generation performance in the quarter further strengthened our balance sheet. We closed the quarter with
Fourth Quarter 2015
Tronox TiO2
TiO2 segment revenue of
ilmenite sales (no sales were made of either product in the year-ago quarter). Selling prices for CP titanium slag, zircon and rutile prime were lower than the year-ago quarter.
Compared sequentially to the third quarter, fourth quarter TiO2 segment revenue of
pigment products inventory continued on its downward trend and ended the year slightly below normal seasonal levels. Sales of titanium feedstocks and co-products, including zircon and rutile products, were 10 percent lower than the third quarter as sales volumes were level and average selling prices declined 10 percent. Zircon, rutile prime and ilmenite sales volumes increased modestly while CP titanium slag sales were lower. Selling prices for CP titanium slag, zircon and rutile prime were lower than the prior quarter.
TiO2 segment adjusted EBITDA of
Capital expenditures in TiO2 of
coupled with efficiency gains expected to be realized in downstream smelting and pigment operations from the mine’s high quality ilmenite feedstock.
Alkali segment revenue of
Alkali adjusted EBITDA of
cash of
Corporate
Corporate adjusted EBITDA was
Consolidated
Selling, general and administrative expenses in the fourth quarter were
Full Year 2015
For the full-year 2015, revenue was
Tronox TiO2
TiO2 segment revenue of
TiO2 segment adjusted EBITDA in 2015 was
Alkali segment pro forma revenue of
Corporate
Corporate adjusted EBITDA was
Consolidated
Selling, general and administrative expenses for the year were
depletion and amortization was
Fourth Quarter 2015 Webcast Conference Call
Internet Broadcast: https://www.tronox.com/
Dial-in telephone numbers:
International: +1.253.237.1184
Conference ID: 32827062
Conference Call Presentation Slides: will be used during the conference call and are available on our website at https://www.tronox.com/
Conference Call Replay: Available via the
Internet Replay: www.tronox.com
Dial-in telephone numbers:
International: +1.404.537.3406
Conference ID: 32827062
Upcoming Conferences
During the first and second quarters 2016 a member of management is scheduled to present at the following conferences:
Alembic Global Advisors Chemical Conference ,Deer Valley , UT,February 25-26, 2016 B. Riley & Co. Annual Investor Conference,Hollywood, CA ,May 25, 2016
Accompanying conference materials will be available at http://investor.tronox.com
About
Forward Looking Statements
Statements in this release that are not historical are forward-looking statements within the meaning of the
filings with the
Moreover, we operate in a very competitive and rapidly changing environment. New risks and uncertainties emerge from time to time, and it is not possible for our management to predict all risks and uncertainties, nor can management assess the impact of all factors on our business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements. Although we believe the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee future results, level of activity, performance or achievements. Neither we nor any other person assumes responsibility for the accuracy or completeness of any of these forward-looking statements. You should not rely upon forward-looking statements as predictions of future events. Unless otherwise required by applicable laws, we
undertake no obligation to update or revise any forward-looking statements, whether as a result of new information or future developments.
Use of Non-
To provide investors and others with additional information regarding
non-
GAAP financial measures to
Management believes these non-
Reflect Tronox Limited’s ongoing business in a manner that allows for meaningful period-to-period comparison and analysis of trends in its business, as they exclude income and expense that are not reflective of ongoing operating results;- Provide useful information to investors and others in understanding and evaluating
Tronox Limited’s operating results and future prospects in the same manner as management and in comparing financial results across accounting periods; - Provide additional view of the operating performance of the company by adding interest expenses, taxes, depreciation, depletion and amortization to the net income. Further adjustments due to purchase accounting and stock-based compensation charges attempt to exclude items that are either non-cash or unusual in nature;
- Assist investors to assess the company’s compliance with financial covenants under its debt instruments;
- Adjusted EBITDA is one of the primary measures management uses for planning and budgeting processes and to monitor and evaluate financial and operating results. Adjusted EBITDA is not a recognized term under
U.S. GAAP and does not purport to be an alternative to measures of our financial performance as determined in accordance withU.S. GAAP, such as net income (loss). Because other companies may calculate EBITDA and Adjusted EBITDA differently thanTronox , EBITDA may not be, and Adjusted EBITDA as presented in this release is not, comparable to similarly titled measures reported by other companies, and - We believe that the non-
U.S. GAAP financial measure “Adjusted net loss attributable toTronox Limited ” and its presentation on a per share basis provide useful information about our operating results to investors and securities analysts. We also believe that excluding the effects of these items from operating results allows management and investors to compare more easily the financial performance of our underlying businesses from period to period.
Media Contact:
Investor Contact:
|
|||||||||||||
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (US GAAP) |
|||||||||||||
(UNAUDITED) |
|||||||||||||
(Millions of |
|||||||||||||
Three Months Ended |
Year Ended |
||||||||||||
2015 |
2014 |
2015 |
2014 |
||||||||||
Net sales |
$ 535 |
$ 400 |
$ 2,112 |
$ 1,737 |
|||||||||
Cost of goods sold |
513 |
346 |
1,992 |
1,530 |
|||||||||
Gross profit |
22 |
54 |
120 |
207 |
|||||||||
Selling, general and administrative expenses |
(46) |
(54) |
(217) |
(192) |
|||||||||
Restructuring expense |
(14) |
(5) |
(21) |
(15) |
|||||||||
Income (loss) from operations |
(38) |
(5) |
(118) |
– |
|||||||||
Interest and debt expense, net |
(45) |
(32) |
(176) |
(133) |
|||||||||
Net loss on liquidation of non-operating subsidiaries |
– |
– |
– |
(35) |
|||||||||
Loss on extinguishment of debt |
– |
– |
– |
(8) |
|||||||||
Other income, net |
6 |
15 |
28 |
27 |
|||||||||
Loss before income taxes |
(77) |
(22) |
(266) |
(149) |
|||||||||
Income tax provision |
(12) |
(253) |
(41) |
(268) |
|||||||||
Net loss |
(89) |
(275) |
(307) |
(417) |
|||||||||
Net income attributable to noncontrolling interest |
1 |
1 |
11 |
10 |
|||||||||
Net loss attributable to |
$ (90) |
$ (276) |
$ (318) |
$ (427) |
|||||||||
Loss per share, basic and diluted |
$ (0.78) |
$ (2.40) |
$ (2.75) |
$ (3.74) |
|||||||||
Weighted average shares outstanding, basic and diluted (in thousands) |
115,673 |
115,036 |
115,566 |
114,281 |
|||||||||
Other Operating Data: |
|||||||||||||
Capital expenditures |
$ 50 |
$ 81 |
$ 191 |
$ 187 |
|||||||||
Depreciation, depletion and amortization expense |
$ 72 |
$ 70 |
$ 294 |
$ 295 |
|
|||||||||||||||
SCHEDULE OF ADJUSTED EARNINGS (NON- |
|||||||||||||||
(UNAUDITED) |
|||||||||||||||
(Millions of |
|||||||||||||||
Three Months Ended |
Year Ended |
||||||||||||||
2015 |
2014 |
2015 |
2014 |
||||||||||||
Net sales |
$ 535 |
$ 400 |
$ 2,112 |
$ 1,737 |
|||||||||||
Cost of goods sold |
513 |
346 |
1,983 |
1,530 |
|||||||||||
Gross profit |
22 |
54 |
129 |
207 |
|||||||||||
Selling, general and administrative expenses |
(46) |
(51) |
(198) |
(189) |
|||||||||||
Adjusted income (loss) from operations |
(24) |
3 |
(69) |
18 |
|||||||||||
Interest and debt expense, net |
(45) |
(32) |
(168) |
(133) |
|||||||||||
Loss on extinguishment of debt |
– |
– |
– |
(8) |
|||||||||||
Other income, net |
6 |
6 |
28 |
18 |
|||||||||||
Adjusted loss before income taxes |
(63) |
(23) |
(209) |
(105) |
|||||||||||
Income tax benefit (provision) |
(12) |
2 |
(41) |
41 |
|||||||||||
Adjusted net loss |
(75) |
(21) |
(250) |
(64) |
|||||||||||
Net income attributable to noncontrolling interest |
1 |
2 |
11 |
11 |
|||||||||||
Adjusted net loss attributable to |
|||||||||||||||
|
$ (76) |
$ (23) |
$ (261) |
$ (75) |
|||||||||||
Basic adjusted loss per share, attributable to |
$ (0.66) |
$ (0.20) |
$ (2.26) |
$ (0.66) |
|||||||||||
Diluted adjusted loss per share, attributable to |
$ (0.66) |
$ (0.20) |
$ (2.26) |
$ (0.66) |
|||||||||||
Weighted average shares outstanding, basic (in thousands) |
115,673 |
115,036 |
115,566 |
114,281 |
|||||||||||
Weighted average shares outstanding, diluted (in thousands) |
115,673 |
115,036 |
115,566 |
114,281 |
* We believe that the non- |
|
||||||||
RECONCILIATION OF NON- |
||||||||
(UNAUDITED) |
||||||||
(Millions of |
||||||||
RECONCILIATION OF NET LOSS |
||||||||
ATTRIBUTABLE TO TRONOX LIMITED ( |
||||||||
TO ADJUSTED NET LOSS |
||||||||
ATTRIBUTABLE TO TRONOX LIMITED (NON- |
||||||||
Three Months Ended |
Year Ended |
|||||||
2015 |
2014 |
2015 |
2014 |
|||||
Net loss attributable to |
$ (90) |
$ (276) |
$ (318) |
$ (427) |
||||
Acquisition related expense (a) |
– |
– |
36 |
– |
||||
Restructuring expense (b) |
14 |
5 |
21 |
15 |
||||
Net loss on liquidation of non-operating subsidiaries (c) |
– |
– |
– |
35 |
||||
Tax valuation allowance in |
– |
255 |
– |
311 |
||||
Tax and noncontrolling impact of restructuring, liquidation of non-operating subsidiaries and acquisition related items (e) |
– |
(1) |
– |
(3) |
||||
Contract settlements, net (f) |
– |
3 |
– |
3 |
||||
Pension and postretirement benefit curtailment gains (g) |
– |
(9) |
– |
(9) |
||||
Adjusted net loss attributable to |
$ (76) |
$ (23) |
$ (261) |
$ (75) |
||||
Diluted loss per share attributable to |
$ (0.78) |
(2.40) |
$ (2.75) |
$ (3.74) |
||||
Acquisition related expense, per diluted share |
– |
– |
0.31 |
– |
||||
Restructuring expense, per diluted share |
0.12 |
0.04 |
0.18 |
0.13 |
||||
Net loss on liquidation of non-operating subsidiaries, per diluted share |
– |
– |
– |
0.31 |
||||
Tax valuation allowance in |
– |
2.22 |
– |
2.72 |
||||
Tax and noncontrolling impact of restructuring, liquidation of non-operating subsidiaries and acquisition related items, per diluted share |
– |
(0.01) |
– |
(0.03) |
||||
Contract settlements, net |
– |
0.03 |
– |
0.03 |
||||
Pension and postretirement benefit curtailment gains |
– |
(0.08) |
– |
(0.08) |
||||
Diluted adjusted loss per share attributable to |
$ (0.66) |
$ (0.20) |
$ (2.26) |
$ (0.66) |
||||
Weighted average shares outstanding, diluted (in thousands) |
115,673 |
115,036 |
115,566 |
114,281 |
||||
(a) One-time non-operating items and the effect of acquisitions. |
||||||||
(b) Represents severance costs associated with the shutdown of our sodium chlorate plant and other global |
||||||||
(c) Represents the liquidation of non-operating subsidiaries, |
||||||||
(d) Represents an adjustment to account for a full valuation allowance for |
||||||||
(e) Represents the tax and noncontrolling impact on items references in notes (a) and (b) |
||||||||
(f) Represents various contract settlements, net of related expenses. |
||||||||
(g) Represents pension curtailment in |
|
||||||||
SEGMENT INFORMATION |
||||||||
(UNAUDITED) |
||||||||
(Millions of |
||||||||
Three Months Ended |
Year Ended |
|||||||
2015 |
2014 |
2015 |
2014 |
|||||
Sales |
||||||||
TiO2segment |
$ 336 |
$ 400 |
$ 1,510 |
$ 1,737 |
||||
Alkali segment |
199 |
– |
602 |
– |
||||
Net sales |
$ 535 |
$ 400 |
$ 2,112 |
$ 1,737 |
||||
Income (loss) from operations |
||||||||
TiO2segment |
$ (65) |
$ 17 |
$ (123) |
$ 78 |
||||
Alkali segment |
23 |
– |
69 |
– |
||||
Corporate |
4 |
(22) |
(64) |
(78) |
||||
Income (loss) from operations |
(38) |
(5) |
(118) |
– |
||||
Interest and debt expense, net |
(45) |
(32) |
(176) |
(133) |
||||
Net loss on liquidation of non-operating subsidiaries |
– |
– |
– |
(35) |
||||
Loss on extinguishment of debt |
– |
– |
– |
(8) |
||||
Other income, net |
6 |
15 |
28 |
27 |
||||
Loss before income taxes |
(77) |
(22) |
(266) |
(149) |
||||
Income tax provision |
(12) |
(253) |
(41) |
(268) |
||||
Net loss |
(89) |
(275) |
(307) |
(417) |
||||
Net income attributable to noncontrolling interest |
1 |
1 |
11 |
10 |
||||
Net loss attributable to |
$ (90) |
$ (276) |
$ (318) |
$ (427) |
|
||||||||
CONDENSED CONSOLIDATED BALANCE SHEETS |
||||||||
(UNAUDITED) |
||||||||
(Millions of |
||||||||
|
|
|||||||
ASSETS |
2015 |
2014 |
||||||
Current Assets |
||||||||
Cash and cash equivalents |
$ 229 |
$ 1,276 |
||||||
Restricted cash |
5 |
3 |
||||||
Accounts receivable, net of allowance for doubtful accounts |
391 |
277 |
||||||
Inventories, net |
630 |
770 |
||||||
Prepaid and other assets |
46 |
42 |
||||||
Deferred tax assets |
– |
13 |
||||||
Total current assets |
1,301 |
2,381 |
||||||
Noncurrent Assets |
||||||||
Property, plant and equipment, net |
1,843 |
1,227 |
||||||
Mineral leaseholds, net |
1,604 |
1,058 |
||||||
Intangible assets, net |
244 |
272 |
||||||
Inventories, net |
12 |
57 |
||||||
Long-term deferred tax assets |
– |
9 |
||||||
Other long-term assets |
68 |
61 |
||||||
Total assets |
$ 5,072 |
$ 5,065 |
||||||
LIABILITIES AND EQUITY |
||||||||
Current Liabilities |
||||||||
Accounts payable |
$ 159 |
$ 160 |
||||||
Accrued liabilities |
180 |
147 |
||||||
Short-term debt |
150 |
– |
||||||
Long-term debt due within one year |
16 |
18 |
||||||
Income taxes payable |
43 |
32 |
||||||
Deferred tax liabilities |
– |
9 |
||||||
Total current liabilities |
548 |
366 |
||||||
Noncurrent Liabilities |
||||||||
Long-term debt |
2,955 |
2,375 |
||||||
Pension and postretirement healthcare benefits |
141 |
172 |
||||||
Asset retirement obligations |
77 |
85 |
||||||
Long-term deferred tax liabilities |
143 |
204 |
||||||
Other long-term liabilities |
98 |
75 |
||||||
Total liabilities |
3,962 |
3,277 |
||||||
Shareholders’ Equity |
||||||||
Tronox Limited Class A ordinary shares, par value |
1 |
1 |
||||||
Tronox Limited Class B ordinary shares, par value |
– |
– |
||||||
Capital in excess of par value |
1,500 |
1,476 |
||||||
Retained earnings |
93 |
529 |
||||||
Accumulated other comprehensive loss |
(596) |
(396) |
||||||
Total shareholders’ equity |
998 |
1,610 |
||||||
Noncontrolling interest |
112 |
178 |
||||||
Total equity |
1,110 |
1,788 |
||||||
Total liabilities and equity |
$ 5,072 |
$ 5,065 |
|
|||
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS |
|||
(UNAUDITED) |
|||
(Millions of |
|||
Year Ended |
|||
2015 |
2014 |
||
Cash Flows from Operating Activities: |
|||
Net loss |
$ (307) |
$ (417) |
|
Adjustments to reconcile net loss to net cash provided by operating activities: |
|||
Depreciation, depletion and amortization |
294 |
295 |
|
Deferred income taxes |
– |
237 |
|
Share-based compensation expense |
22 |
20 |
|
Amortization of deferred debt issuance costs and discount on debt |
11 |
10 |
|
Pension and postretirement healthcare benefit (income) expense |
5 |
(3) |
|
Net loss on liquidation of non-operating subsidiaries |
– |
35 |
|
Loss on extinguishment of debt |
– |
8 |
|
Amortization of fair value inventory step-up |
9 |
– |
|
Other noncash items affecting net loss |
– |
3 |
|
Contributions to employee pension and postretirement plans |
(17) |
(18) |
|
Changes in assets and liabilities: |
|||
(Increase) decrease in accounts receivable |
20 |
23 |
|
(Increase) decrease in inventories |
157 |
(101) |
|
(Increase) decrease in prepaid and other assets |
18 |
9 |
|
Increase (decrease) in accounts payable and accrued liabilities |
(12) |
22 |
|
Increase (decrease) in income taxes payable |
20 |
20 |
|
Other, net |
(4) |
(2) |
|
Cash provided by operating activities |
216 |
141 |
|
Cash Flows from Investing Activities: |
|||
Capital expenditures |
(191) |
(187) |
|
Proceeds from the sale of assets |
1 |
– |
|
Acquisition of business |
(1,650) |
– |
|
Cash used in investing activities |
(1,840) |
(187) |
|
Cash Flows from Financing Activities: |
|||
Repayments of debt |
(18) |
(20) |
|
Proceeds from debt |
750 |
– |
|
Debt issuance costs |
(15) |
(2) |
|
Dividends paid |
(117) |
(116) |
|
Proceeds from the exercise of warrants and options |
3 |
6 |
|
Cash provided by (used in) financing activities |
603 |
(132) |
|
Effects of exchange rate changes on cash and cash equivalents |
(26) |
(21) |
|
Net decrease in cash and cash equivalents |
(1,047) |
(199) |
|
Cash and cash equivalents at beginning of period |
1,276 |
1,475 |
|
Cash and cash equivalents at end of period |
$ 229 |
$ 1,276 |
|
|||||||||||||||
CONDENSED STATEMENT OF FREE CASH FLOWS |
|||||||||||||||
(UNAUDITED) |
|||||||||||||||
(Millions of |
|||||||||||||||
Three Months Ended |
Year Ended |
||||||||||||||
TiO2 |
Alkali |
Corporate |
Consolidated |
TiO2 |
Alkali |
Corporate |
Consolidated |
||||||||
Operating income (loss) |
$ (65) |
$ 23 |
$ 4 |
$ (38) |
$ (123) |
$ 69 |
$ (64) |
$ (118) |
|||||||
Depreciation, depletion and amortization expense |
57 |
14 |
1 |
72 |
246 |
42 |
6 |
294 |
|||||||
Other |
44 |
1 |
(19) |
26 |
92 |
18 |
(14) |
96 |
|||||||
Adjusted EBITDA |
$ 36 |
$ 38 |
$ (14) |
$ 60 |
$ 215 |
$ 129 |
$ (72) |
$ 272 |
|||||||
Adjusted EBITDA |
$ 36 |
$ 38 |
$ (14) |
$ 60 |
$ 215 |
$ 129 |
$ (72) |
$ 272 |
|||||||
Interest paid, net of capitalized interest and interest income |
– |
– |
(15) |
(15) |
– |
– |
(145) |
(145) |
|||||||
Income tax provision |
– |
– |
(12) |
(12) |
– |
– |
(41) |
(41) |
|||||||
Alkali transaction costs |
– |
– |
– |
– |
– |
– |
(29) |
(29) |
|||||||
Contributions to employee pension and |
(1) |
– |
– |
(1) |
(15) |
(2) |
– |
(17) |
|||||||
Deferred income taxes |
– |
– |
4 |
4 |
– |
– |
– |
– |
|||||||
Other |
(14) |
– |
(14) |
(28) |
(20) |
– |
(3) |
(23) |
|||||||
Changes in assets and liabilities |
|||||||||||||||
(Increase) decrease in accounts receivable |
46 |
10 |
– |
56 |
11 |
9 |
– |
20 |
|||||||
(Increase) decrease in inventories |
62 |
5 |
– |
67 |
155 |
2 |
– |
157 |
|||||||
(Increase) decrease in prepaid and other assets |
7 |
6 |
1 |
14 |
6 |
15 |
(3) |
18 |
|||||||
Increase (decrease) in accounts payable and accrued liabilities |
15 |
(13) |
21 |
23 |
8 |
– |
(20) |
(12) |
|||||||
Increase (decrease) in income taxes payable |
– |
– |
8 |
8 |
– |
– |
20 |
20 |
|||||||
Other, net |
– |
– |
(5) |
(5) |
– |
– |
(4) |
(4) |
|||||||
Subtotal |
130 |
8 |
25 |
163 |
180 |
26 |
(7) |
199 |
|||||||
Cash provided by (used in) operating activities |
151 |
46 |
(26) |
171 |
360 |
153 |
(297) |
216 |
|||||||
Capital expenditures |
37 |
13 |
– |
50 |
164 |
26 |
1 |
191 |
|||||||
Free cash flow |
$ 114 |
$ 33 |
$ (26) |
$ 121 |
$ 196 |
$ 127 |
$ (298) |
$ 25 |
|
|||||||||
RECONCILIATION OF NET LOSS TO EBITDA AND ADJUSTED EBITDA (NON- |
|||||||||
(UNAUDITED) |
|||||||||
(Millions of |
|||||||||
Three Months Ended |
Year Ended |
||||||||
2015 |
2014 |
2015 |
2014 |
||||||
Net loss |
$ (89) |
$ (275) |
$ (307) |
$ (417) |
|||||
Interest and debt expense, net |
45 |
32 |
176 |
133 |
|||||
Interest income |
(2) |
(3) |
(7) |
(13) |
|||||
Income tax provision |
12 |
253 |
41 |
268 |
|||||
Depreciation, depletion and amortization expense |
72 |
70 |
294 |
295 |
|||||
EBITDA |
38 |
77 |
197 |
266 |
|||||
Amortization of inventory step-up from purchase accounting |
– |
– |
9 |
– |
|||||
Adjustment of transfer tax due to 2012 acquisition |
– |
– |
(11) |
– |
|||||
Alkali transaction costs (a) |
– |
– |
29 |
– |
|||||
Share-based compensation |
5 |
5 |
22 |
22 |
|||||
Restructuring expense |
14 |
5 |
21 |
15 |
|||||
Net loss on liquidation of non-operating subsidiaries |
– |
– |
– |
35 |
|||||
Loss on extinguishment of debt |
– |
– |
– |
8 |
|||||
Pension and postretirement benefit curtailment gains |
– |
(9) |
– |
(9) |
|||||
Foreign currency remeasurement |
(5) |
(4) |
(21) |
(4) |
|||||
Other items (b) |
8 |
7 |
26 |
20 |
|||||
Adjusted EBITDA |
$ 60 |
$ 81 |
$ 272 |
$ 353 |
|||||
Adjusted EBITDA by Segment |
|||||||||
Tio2 segment |
$ 36 |
$ 107 |
$ 215 |
$ 437 |
|||||
Alkali segment |
38 |
– |
129 |
– |
|||||
Corporate |
(14) |
(26) |
(72) |
(84) |
|||||
$ 60 |
$ 81 |
$ 272 |
$ 353 |
(a) |
Transaction costs consist of costs associated with the acquisition of the Alkali business, including banking fees, legal and professional fees. |
||||||||
(b) |
Includes noncash pension and postretirement costs, severance expense, and other items. |
Logo – http://photos.prnewswire.com/prnh/20131106/DA11850LOGO
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/tronox-reports-fourth-quarter-2015-financial-results-300224945.html
SOURCE
News Provided by Acquire Media